Table 5.
TCT positive rates of different ages
| Age (years) | N | NILM, n (%a) | ASC, n (%a) | LSIL, n (%a) | HSIL, n (%a) | TCT positive, n (%a) |
|---|---|---|---|---|---|---|
| < 30 | 4046 | 3722 (91.99) | 181 (4.47) | 123 (3.04) | 20 (0.49) | 324 (8.01) |
| 30–40 | 7666 | 7066 (92.17) | 300 (3.91) | 198 (2.58) | 102 (1.33) | 600 (7.83) |
| 40–50 | 5014 | 4575 (91.24) | 212 (4.23) | 131 (2.61) | 96 (1.91) | 439 (8.76) |
| 50–60 | 3157 | 2889 (91.51) | 115 (3.64) | 80 (2.53) | 73 (2.31) | 268 (8.49) |
| > 60 | 1356 | 1241 (91.52) | 50 (3.69) | 29 (2.14) | 36 (2.65) | 115 (8.48) |
| Total | 21,239 | 19,493 | 858 | 561 | 327 | 1746 |
TCT thinprep cytology test, NILM negative for intraepithelial lesions or malignancy, ASC atypical squamous cells, LSIL low grade squamous intraepithelial lesion, HSIL high grade squamous intraepithelial lesion
a Represented TCT positive rates in different age categories